Inhibitors of akt activity
    3.
    发明申请
    Inhibitors of akt activity 失效
    akt活性抑制剂

    公开(公告)号:US20070082906A1

    公开(公告)日:2007-04-12

    申请号:US10554186

    申请日:2004-04-20

    IPC分类号: A61K31/53 C07D403/02

    摘要: The present invention is directed to compounds which contain a heterocyclic triazine moiety which inhibit the activity of Akt, a serine/threonine protein kinase. The invention is further directed to chemotherapeutic compositions containing the compounds of this invention and methods for treating cancer comprising administration of the compounds of the invention.

    摘要翻译: 本发明涉及含有抑制Akt(丝氨酸/苏氨酸蛋白激酶)活性的杂环三嗪部分的化合物。 本发明还涉及含有本发明化合物的治疗组合物和治疗癌症的方法,包括施用本发明化合物。

    Inhibitors of akt activity
    6.
    发明申请
    Inhibitors of akt activity 失效
    akt活性抑制剂

    公开(公告)号:US20060205765A1

    公开(公告)日:2006-09-14

    申请号:US10554185

    申请日:2004-04-20

    CPC分类号: C07D487/04 C07D471/04

    摘要: The present invention is directed to compounds which contain a five-membered heterocyclic ring fused to a substituted pyridine moiety which inhibit the activity of Akt, a serine/threonine protein kinase. The invention is further directed to chemotherapeutic compositions containing the compounds of this invention and methods for treating cancer comprising administration of the compounds of the invention.

    摘要翻译: 本发明涉及含有与取代的吡啶部分稠合的五元杂环的化合物,所述取代吡啶部分抑制丝氨酸/苏氨酸蛋白激酶Akt的活性。 本发明还涉及含有本发明化合物的治疗组合物和治疗癌症的方法,包括施用本发明化合物。

    Tyrosine kinase inhibitors
    9.
    发明申请
    Tyrosine kinase inhibitors 审中-公开
    酪氨酸激酶抑制剂

    公开(公告)号:US20050228031A1

    公开(公告)日:2005-10-13

    申请号:US10823156

    申请日:2004-04-13

    摘要: The present invention relates to compounds which inhibit, regulate and/or modulate tyrosine kinase signal transduction, compositions which contain these compounds, and methods of using them to treat tyrosine kinase-dependent diseases and conditions, such as angiogenesis, cancer, tumor growth, atherosclerosis, age related macular degeneration, diabetic retinopathy, inflammatory diseases, and the like in mammals.

    摘要翻译: 本发明涉及抑制,调节和/或调节酪氨酸激酶信号转导的化合物,含有这些化合物的组合物及其用于治疗酪氨酸激酶依赖性疾病和病症如血管生成,癌症,肿瘤生长,动脉粥样硬化的方法 ,年龄相关性黄斑变性,糖尿病性视网膜病变,炎症性疾病等。

    Systems and methods of monitoring a motor load
    10.
    发明授权
    Systems and methods of monitoring a motor load 有权
    监测电机负载的系统和方法

    公开(公告)号:US07205737B1

    公开(公告)日:2007-04-17

    申请号:US11324818

    申请日:2006-01-04

    申请人: Mark Bilodeau

    发明人: Mark Bilodeau

    IPC分类号: H02K17/32

    摘要: Systems and methods of detecting an overload condition. In one embodiment, a method of monitoring a load of a DC motor includes intermittently de-energizing the motor; monitoring a first voltage; and measuring a first interval of time between a starting time and an ending time, wherein the starting time comprises the time at which the motor is de-energized and the ending time comprises a time at which the first voltage and a reference voltage have substantially similar values.

    摘要翻译: 检测过载条件的系统和方法。 在一个实施例中,监视直流电动机的负载的方法包括间歇地使电动机断电; 监测第一电压; 并且测量起始时间和结束时间之间的第一时间间隔,其中所述起动时间包括所述电动机断电的时间,并且所述结束时间包括所述第一电压和参考电压具有基本相似的时间 价值观。